Shorter breast radiation after surgery for low-risk breast cancer
Part of Cancer, Injuries & trauma, Skin clinical trials.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (invasive or non-invasive) breast cancer and have had breast surgery (lumpectomy or mastectomy) with lymph node checking.
- Your cancer stage is low: ypT0-2N0-1 (if you had chemo/other treatment before surgery) or pT0-2N0-1 (if you had surgery first).
- There is no distant spread (no metastasis).
- You have not already had radiation to the same side breast, lymph-drainage areas, or nearby regions.
- You must have acceptable blood work and organ health (kidneys and liver) to safely receive radiation.
- You must be able to attend follow-ups and sign consent; if you could get pregnant, you must use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
This study tests a shorter course of radiation therapy after breast reconstruction surgery for people with breast cancer. It aims to see if fewer, larger doses of radiation are safe and effective after mastectomy with reconstruction.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.